{"id":550663,"date":"2021-06-30T23:06:02","date_gmt":"2021-06-30T23:06:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=550663"},"modified":"2021-06-30T23:06:02","modified_gmt":"2021-06-30T23:06:02","slug":"keratoconus-market-share-trends-epidemiology-forecast-till-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/keratoconus-market-share-trends-epidemiology-forecast-till-2030_550663.html","title":{"rendered":"Keratoconus Market, Share, Trends, Epidemiology Forecast Till 2030"},"content":{"rendered":"
\"Keratoconus<\/a><\/p>\n
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u201d Keratoconus Market Insights, Epidemiology, and Market Forecast-2030\u2033 report delivers an in-depth understanding of the Keratoconus, historical and forecasted epidemiology as well as the Keratoconus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.\n<\/div>\n

Keratoconus is an eye disorder characterized by progressive thinning and changes in the shape of the cornea.<\/p>\n

The initial Keratoconus treatment often consists of hard contact lenses. A variety of keratorefractive procedures have also been attempted, broadly divided into subtractive and additive techniques. Subtractive techniques include photorefractive keratectomy or laser in situ keratomileusis, although generally, the results of these techniques have been poor. Implantation of intrastromal corneal ring segments is an additive technique in which the implants are intended to reinforce the cornea, prevent further deterioration, and potentially obviate the need for penetrating keratoplasty. Penetrating keratoplasty (i.e., corneal grafting) is the last line of treatment.<\/p>\n

The current Keratoconus treatment option includes Intrastromal corneal ring segments (ICRS), Corneal reshaping and Cross-Linking (CXL) along with Riboflavin solutions + UV Light, Keratoplasty and Others (Antihistamine\/mast cell–stabilizing topical medications, antihistamines, mast cell stabilizers, nonsteroidal anti-inflammatory (NSAID), which provide the corneal clinicians a variety of treatment options for the visual rehabilitation of Keratoconus patients. In the mild forms of Keratoconus , eyeglasses or soft contact lenses are preferred, however, their market has been excluded from the forecast model.  <\/p>\n

Keratoconus Market Insight<\/strong><\/p>\n

Keratoconus market size in 7MM in 2017 was USD 2,456 million <\/a><\/strong><\/p>\n

 <\/p>\n

Keratoconus Market Driver<\/a><\/strong><\/p>\n